From NeuroLex
| Category:1-120 Truncated Alpha-Synuclein Drosophila |
| Authors | Magali Periquet +, Tudor Fulga +, Liisa Myllykangas +, Michael G. Schlossmacher +, and Mel B. Feany + |
|---|---|
| CurationStatus | uncurated + |
| Definition | This transgenic drosophila expresses a for … This transgenic drosophila expresses a form of alpha-synuclein that is a C-terminally truncated fragment comprising amino acids 1-120. This form of alpha-synuclein has an enhanced ability to aggregate and thus enhanced neurotoxicity. This mutant is used in research to determine the role of alpha-synuclein aggregation in neurodegenerative diseases, such as Parkinsons. degenerative diseases, such as Parkinsons. |
| Figure | 1-3 + |
| Id | nlx_organ_090801 + |
| JournalNumber | 12 + |
| JournalVolume | 27 + |
| Label | 1-120 Truncated Alpha-Synuclein Drosophila + |
| Modification dateThis property is a special property in this wiki. | 28 October 2009 01:05:57 + |
| ModifiedDate | 28 October 2009 + |
| PMID | 17376994 + |
| Pages | 3338-3346 |
| PublicationDate | March 21 +, 2007 + |
| PublicationName | The Journal of Neuroscience + |
| Title | Aggregated Alpha-Synuclein Mediates Dopaminergic Neurotoxicity In Vivo + |
| Categories | Mutant Drosophila |
| hide properties that link here |
| No properties link to this page. |